TTRX Insider Trading Activity and SEC Form 4 Filings
TTRX insider trading summary
Over the past 12 months, insiders at Turn Therapeutics Inc. (TTRX) reported 6 open-market purchases worth $118K by 2 insiders and no sales on SEC Form 4. Net insider buying was $118K.
Latest TTRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 12, 2025 | Zuraiz Chaudhary | See Remarks | Buy | $9K (2,500 @ $3.50) |
| Nov 24, 2025 | Arthur F Golden | Director | Buy | $34K (9,868 @ $3.44) |
| Nov 21, 2025 | Zuraiz Chaudhary | See Remarks | Buy | $3K (1,000 @ $3.29) |
| Nov 21, 2025 | Arthur F Golden | Director | Buy | $59K (20,532 @ $2.87) |
| Nov 20, 2025 | Zuraiz Chaudhary | See Remarks | Buy | $4K (1,450 @ $2.61) |
| Nov 17, 2025 | Zuraiz Chaudhary | See Remarks | Buy | $9K (2,500 @ $3.62) |
| Oct 23, 2025 | Abraham Chesed | Insider | Buy | $66K (14,286 @ $4.60) |
| Oct 23, 2025 | Arthur F Golden | Director | Buy | $100K (20,202 @ $4.95) |
| Oct 23, 2025 | Zuraiz Chaudhary | See Remarks | Buy | $25K (5,050 @ $4.95) |
| Nov 29, 2007 | Aaron Cohen | Director | Buy | $2K (5,000 @ $0.33) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.